All In Biotech

Drug Trial Radar · NCT07836647

An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD

Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Sep 25, 2026

Primary completion

Feb 2028

Study completion Feb 2028

Sponsor

Lead sponsor
Transcend TherapeuticsIndustry
Sponsor type
Industry
First posted
Sep 23, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is evaluating the safety and efficacy of TSND-201 in adults with PTSD. Eligible participants will enter a 4-week Treatment Period where they will be randomized 1:1:1 to receive one of two doses of TSND-201 or placebo, once per week. Following the Treatment Period, participants will enter an 8-week Follow-up Period.

Conditions

  • Post Traumatic Stress Disorder

Interventions

  • TSND-201Drug

    TSND-201 capsules, given orally, once a week for four consecutive weeks

  • PlaceboDrug

    Placebo capsules, given orally, once a week for four consecutive weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) Total Severity ScoreTime frame: Up to 12 Weeks

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Mountain View Clinical Research

    Denver, Colorado · Recruiting

  • Bradenton Research Center

    Bradenton, Florida · Recruiting

  • CNS Healthcare

    Orlando, Florida · Recruiting

  • CenExel Tampa

    Tampa, Florida · Recruiting

  • K2 Medical Research Tampa

    Tampa, Florida · Recruiting

  • CenExel Atlanta

    Atlanta, Georgia · Recruiting

  • CenExel Marlton

    Marlton, New Jersey · Recruiting

  • Bio Behavioral Health

    Toms River, New Jersey · Recruiting

  • Cedar Clinical Research

    Draper, Utah · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.